Equity Overview
Price & Market Data
Price: $0.96
Daily Change: +$0.04 / 4.17%
Range: $0.873 - $0.979
Market Cap: $22,704,960
Volume: 95,829
Performance Metrics
1 Week: 11.63%
1 Month: -11.93%
3 Months: -19.33%
6 Months: -37.25%
1 Year: -24.41%
YTD: -17.95%
Company Details
Employees: 49
Sector: Health technology
Industry: Biotechnology
Country: Israel
Details
Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra, which is in phase II clinical trial for the treatment of organ dysfunction caused by sepsis. The company also develops Allocetra for the treatment of moderate knee osteoarthritis and end-stage knee osteoarthritis which is in phase I/II clinical trial. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.